NexGel Acquired All Assets of Silly George for $400,000 in Cash, $200,000 in NEXGEL Common Stk, and a 4-Yr Net Profit Earn Out >NXGL
NexGel Acquired All Assets of Silly George for $400,000 in Cash, $200,000 in NEXGEL Common Stk, and a 4-Yr Net Profit Earn Out >NXGL
Express News | Nexgel Acquires International Beauty Brand, Silly George
NexGel: Silly George Is on a Rev Run Rate of $2M >NXGL
NexGel: Silly George Is on a Rev Run Rate of $2M >NXGL
Analysts Are Bullish on These Healthcare Stocks: Talphera (TLPH), NexGel Inc (NXGL)
Earnings Call Summary | NexGel(NXGL.US) Q1 2024 Earnings Conference
The following is a summary of the NEXGEL, Inc. (NXGL) Q1 2024 Earnings Call Transcript:Financial Performance:NEXGEL reported Q1 revenue of approximately $1.27 million, up by 104% year-over-year, excee
NEXGEL, Inc. (NXGL) Q1 2024 Earnings Call Transcript
NEXGEL, Inc. (NXGL) Q1 2024 Earnings Call Transcript
NEXGEL Reports EPS of -$0.14, Revenue of $1.27M
10-Q: Quarterly report
NexGel: Nearly Finished Capacity Expansion of Texas Facility in Preparation for Pdt Launches With Abbvie, Others >NXGL
NexGel: Nearly Finished Capacity Expansion of Texas Facility in Preparation for Pdt Launches With Abbvie, Others >NXGL
Earnings Flash (NXGL) NEXGEL Reports Q1 Revenue $1.3M, Vs. Street Est of $1.2M
04:10 PM EDT, 05/13/2024 (MT Newswires) -- Earnings Flash (NXGL) NEXGEL Reports Q1 Revenue $1.3M, vs. Street Est of $1.2M
NexGel 1Q Rev $1.27M >NXGL
NexGel 1Q Rev $1.27M >NXGL
NexGel Q1 2024 GAAP EPS $(0.14) Beats $(0.18) Estimate, Sales $1.266M Beat $1.207M Estimate
NexGel (NASDAQ:NXGL) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.18) by 22.22 percent. This is a 6.67 percent increase over losses of $(0.15) per sh
Express News | Nexgel Reports First Quarter 2024 Revenue of $1.27 Million, an Increase of 104% Year-Over-Year
NEXGEL to Report First Quarter 2024 Financial Results on May 13th
Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., May 09, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a leading provider of medical and
NEXGEL to Present at the Aegis Capital Virtual Conference on May 9, 2024
LANGHORNE, Pa., May 06, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content
NEXGEL to Present at the Planet MicroCap Showcase: VEGAS 2024, May 1 & 2, 2024
LANGHORNE, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle
NexGel Inc: Sustained Buy Rating Amid Growth and Strategic Positivity
NEXGEL, Inc. (NASDAQ:NXGL) Q4 2023 Earnings Call Transcript
Earnings Call Summary | NexGel(NXGL.US) Q4 2023 Earnings Conference
The following is a summary of the NEXGEL, Inc. (NXGL) Q4 2023 Earnings Call Transcript:Financial Performance:NEXGEL reported a nearly 100% revenue growth during 2023, amounting to approximately $4.1 m
Express News | NexGel Shares Are Trading Lower After the Company Reported Worse-than-expected Q4 Financial Results
No Data